Delivery Order SPE2DB22D2211-SPE2DB25FSFWF
- Not listed
- The Defense Logistics Agency awarded a $15,543.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,637.91 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.99 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with a completion date of March 6, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,390.75 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance, which notably aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a $1,555.93 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,051.36 by the Defense Logistics Agency (DLA) for the supply of Clobazam 10 mg tablets (100 count) to be performed at the contractor's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 20, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $3,724.61 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 22, 2025, with completion expected by September 23, 2025. This is a firm fixed price contract with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $1,015.46 under a firm fixed price contract. This award represents a non-set-aside competitive procurement processed as a delivery order, with an ultimate completion date of September 25, 2025. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,555.93 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count) with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFWFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,555.93 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with a completion date of September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, vaccines, and other critical medical commodities. The company's track record of non-set-aside, competitively awarded contracts with DLA demonstrates its capability to meet federal procurement requirements for diverse pharmaceutical needs across the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/24/25 |